OnlySky Chooses Kibo for Its Composable Architecture to Scale Independent Ski Businesses
With Kibo’s composable architecture, OnlySky can efficiently integrate cart and checkout capabilities and test new…
With Kibo’s composable architecture, OnlySky can efficiently integrate cart and checkout capabilities and test new…
LONDON and NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — The board of directors of…
WATERLOO, Ontario, Sept. 07, 2022 (GLOBE NEWSWIRE) — High Q Technologies Inc. is an innovative…
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Two Additional Distribution Partnerships Will Target Thousands of Additional Colorado Retail Stores Strong Pilot Results…
Boca Raton, FL, Sept. 07, 2022 (GLOBE NEWSWIRE) — INmune Bio (NASDAQ: INMB), a clinical-…
FORT LEE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a…
SOLANA BEACH, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
BERKELEY HEIGHTS, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Top Executives Bring Expertise to Further Fuel Company Growth Tamara Elias, MD Tamara Elias, MD,…
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
FLORHAM PARK, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
ISELIN, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial…
CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
SAN CARLOS, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Proof-of-Concept Established in Phase 2 Trial of TGCT, with Positive Efficacy Results Across Multiple Clinical…
CONSHOHOCKEN, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage…